Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Nov 29;16(11):e74794.
doi: 10.7759/cureus.74794. eCollection 2024 Nov.

Dissociative Identity Disorder Cotreated With Zinc and L-carnosine: A Case Report

Kensaku Sakae  1   2 , Machi Suka  2 , Hiroyuki Yanagisawa  2
Affiliations
Case Reports

Dissociative Identity Disorder Cotreated With Zinc and L-carnosine: A Case Report

Kensaku Sakae et al. Cureus. .

Abstract

Little is known about the effectiveness of pharmacotherapy in dissociative identity disorder (DID). Zinc is essential for proper brain function. Its deficiency can lead to mental health symptoms, possibly contributing to dissociation. L-carnosine is an endogenous dipeptide with a neuroprotective effect. We report on the case of a 30-year-old woman with DID and comorbid bipolar I disorder who had zinc deficiency and was successfully cotreated with zinc and L-carnosine. She displayed three alternate identities and exhibited signs of emotional/mood instability, flashbacks, binge eating, and self-harm. The patient also displayed several physical symptoms of zinc deficiency. She did not respond to aripiprazole (0.75 mg/d) and clonazepam (1.5 mg/d), but responded marginally to five months of zinc (50 mg/d) supplementation. Simultaneous administration of L-carnosine, gradually increased from 0.5 g/d to 2 g/d over four months, markedly improved her symptoms. Five months after adding 2 g/d L-carnosine, the patient's pronounced alternate identities that people around her could notice no longer appeared. However, the identities that were not noticeable to the people remained. They disappeared completely two years later and reappeared only when zinc and L-carnosine were discontinued during the subsequent three-year follow-up. The patient's severity scores for dissociation and depression were reduced. Furthermore, signs of emotional/mood instability, flashbacks, binge eating, and self-harm improved. The physical symptoms of zinc deficiency eventually resolved. Further investigation of cotreatment with zinc and L-carnosine for DID and related conditions, particularly the contribution of zinc deficiency to dissociation, is necessary.

Keywords: binge eating; bipolar disorder; dissociation; dissociative identity disorder; flashback; glutamate; l-carnosine; self-harm; zinc; zinc deficiency.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. The Institutional Review Board of Keieikai Yashio Hospital issued approval #29-1. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Course of treatment
Bands indicate symptom trajectory. Between 18 and 46 months of treatment, the zinc dosage was 25 mg/d. At 41 months of treatment, the patient received a farewell message from alternate identity (A), and the identity alteration was resolved. However, it recurred when zinc and L-carnosine were discontinued several times thereafter (not shown here). DES: Dissociative Experiences Scale; QIDS-SR16: 16-item Quick Inventory of Depressive Symptomatology (self-report)
See this image and copyright information in PMC

References

    1. American Psychiatric Association. Washington, DC: American Psychiatric Publishing; 2013. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition.
    1. Recent research on the interventions for people with dissociation. Fung HW, Ross CA, Lam SKK, Hung SL. Eur J Trauma Dissociation. 2022;6:100299.
    1. Treatment of dissociative symptoms with opioid antagonists: a systematic review. Escamilla I, Juan N, Peñalva C, Sánchez-Llorens M, Renau J, Benito A, Haro G. Eur J Psychotraumatol. 2023;14:2265184. - PMC - PubMed
    1. Glutamate and post-traumatic stress disorder: toward a psychobiology of dissociation. Chambers RA, Bremner JD, Moghaddam B, Southwick SM, Charney DS, Krystal JH. https://pubmed.ncbi.nlm.nih.gov/10553033/ Semin Clin Neuropsychiatry. 1999;4:274–281. - PubMed
    1. Zinc, future mono/adjunctive therapy for depression: mechanisms of antidepressant action. Nowak G. Pharmacol Rep. 2015;67:659–662. - PubMed

Publication types

LinkOut - more resources